Continuous Glucose Monitor Medicare Coverage | Simple Rules

Medicare Part B can pay for therapeutic continuous glucose monitors when you have diabetes, meet coverage rules, and use an approved device.

Continuous glucose monitoring gives a rolling picture of your blood sugar instead of scattered finger stick readings. For people on Medicare, the natural next question is whether this technology fits within their health coverage and what hoops they often need to clear.

This guide explains how Medicare treats continuous glucose monitors, who can qualify, what costs to expect, and how to keep the paperwork clean. The aim is to turn dense policy language into plain steps that you and your care team can act on without guesswork at every visit.

What A Continuous Glucose Monitor Does

A continuous glucose monitor, or CGM, uses a tiny sensor just under the skin to measure glucose in the fluid between cells. A transmitter sends those readings to a receiver, phone, or insulin pump, where you can see levels and trend arrows in near real time.

The system can send alerts when glucose drifts too low or too high, which helps many people respond before symptoms grow severe. It also reduces the number of finger sticks needed each day, since approved therapeutic systems can guide insulin dosing directly.

Because these devices shape daily treatment decisions and are worn for long periods, Medicare classifies therapeutic CGM systems as durable medical equipment rather than as simple testing supplies.

Medicare Coverage For Continuous Glucose Monitors At A Glance

Under Original Medicare, most therapeutic CGM systems fall under Part B. Once you meet the yearly Part B deductible, you usually pay twenty percent of the Medicare approved amount for the device, sensors, and transmitters, and Medicare pays the remaining share.

Medicare lays out these basics on its page on therapeutic continuous glucose monitors. To qualify for this category, the Food and Drug Administration must allow the device to replace meter readings when you decide how much insulin to take, instead of acting only as a secondary check.

Medicare Advantage plans must cover CGM devices at least to the same level as Original Medicare, but copays, supplier networks, and prior authorization rules can differ. People who pair Original Medicare with a Medigap plan may see their share of Part B coinsurance reduced or removed, depending on the letter plan they hold.

Who Meets Current Medicare Eligibility Rules

To receive coverage, you need to meet medical criteria and process requirements. You must have a diagnosis of diabetes, whether type one or type two, and either use insulin or have a history of dangerous low glucose episodes that your clinician can document.

The American Diabetes Association describes the expanded criteria in its Medicare CGM coverage FAQ. Under updated rules, people do not need to take a set number of daily insulin doses to qualify, and some people who do not use insulin can gain access if they face recurring severe hypoglycemia.

Medicare also expects that you or a caregiver can safely run the system. Your treating clinician needs to confirm that you have received training and understand how to insert sensors, respond to alarms, and act on readings. In addition, there must be a recent visit focused on diabetes care and ongoing visits while you use the device.

Coverage Requirement	What Medicare Looks For	What It Means For You
Diabetes diagnosis	Type 1 or type 2 diabetes listed in the medical record	Your chart must clearly show the diagnosis
Insulin or severe low glucose	Insulin therapy or history of problematic hypoglycemia	Notes should describe insulin use or documented lows
Therapeutic CGM device	Device allowed to replace meter readings for treatment	Your ordered system must qualify as therapeutic
Training and ability	Clinician attests that you or a caregiver can use the device	You may complete education or hands on teaching
Recent diabetes visit	Visit for diabetes care within the past six months	You see your clinician to review control and treatment
Ongoing follow up	Regular in person or telehealth visits while using CGM	You keep scheduled appointments and share reports
Enrolled supplier	Supplier that meets Medicare rules for billing CGM	You order through a company set up to bill Medicare

How Different Medicare Plans Handle CGM Costs

Under Original Medicare, Part B pays its share for approved CGM equipment and supplies once the deductible is met. You then pay coinsurance based on the Medicare allowed charge, and any secondary coverage such as a Medigap plan may help with that amount.

Some Medicare Advantage plans ask you to use specific mail order suppliers, while others allow certain local durable medical equipment stores or pharmacies to provide sensors and transmitters. Plan documents spell out which companies you can use, so it helps to review the durable medical equipment section and the list of diabetes supplies in detail.

Consumer resources such as AARP guidance on Medicare CGM coverage summarize the broad picture: CGM systems fall under Part B as durable medical equipment for people who meet the medical rules, and out of pocket costs then depend on coinsurance, Medigap coverage, and any extra plan rules.

Continuous Glucose Monitor Medicare Coverage Details Worth Checking

Even when you meet the medical criteria, details at the plan and supplier level can slow or block coverage. Brand selection, prior authorization, and how your clinician sends documentation all influence how smoothly the order moves from prescription to shipment.

Different plans may favor different CGM brands, as long as each one qualifies as therapeutic under Medicare rules. Checking whether your preferred device appears on the plan list or in the formulary can prevent late surprises.

The Centers for Medicare and Medicaid Services also publish a detailed article on glucose monitor coverage and coding. The document titled Glucose Monitor Policy Article A52464 explains how receivers, sensors, and supply allowances are treated under Part B billing rules, which shapes how suppliers process claims.

Steps To Get A Continuous Glucose Monitor With Medicare

Moving from interest to an approved device follows a clear sequence you can track step by step. When you understand each step, it becomes easier to see where paperwork stands and where delays arise.

Start with a visit to the clinician who manages your diabetes care. Share records of low glucose events, patterns of wide swings, or barriers to checking with a meter often enough. The visit note should mention your diabetes type, insulin use or severe lows, and the plan to begin a therapeutic CGM under Medicare coverage.

Once the prescription is written, a Medicare enrolled supplier gathers needed documents from your clinician. That usually includes recent visit notes, medication lists, and confirmation that you have been trained or will be trained to use the system safely. After everything is on file, the supplier ships the device and billing flows through Part B.

Topic	Questions To Ask	Why It Matters
Plan coverage	Is this CGM brand covered under my current Medicare plan?	Confirms that the device fits written plan rules
Supplier choice	Which suppliers or pharmacies can bill my plan for CGM?	Helps you avoid bills from out of network companies
Out of pocket costs	After my deductible, what share do I pay for each shipment?	Gives a clear view of ongoing coinsurance
Refill timing	How often will sensors and other supplies ship?	Prevents gaps in coverage when a sensor cycle ends
Prior authorization	Does this device need plan approval before shipping?	Reveals whether extra forms must be completed
Appeal rights	If my claim is denied, what steps can I take to challenge it?	Helps you prepare records for a possible appeal

Handling Claim Denials Or Delays

Even clean applications sometimes run into denials or slow processing. Common reasons include missing visit notes, an incorrect diagnosis code, or confusion about whether the ordered device meets therapeutic rules.

If a claim is denied, read the notice carefully and share it with both your supplier and your clinician. In many cases the solution is to send updated notes, clarify insulin use, or correct a code so it matches Medicare expectations.

Groups such as the American Diabetes Association track rule changes and offer plain language help on their CGM policy pages. These resources explain policy shifts, including the 2023 change that opened coverage to more people who use lower insulin doses or who face severe hypoglycemia without insulin.

Using A Covered CGM In Daily Life

Once your device arrives, good setup and habits turn coverage into results you can feel in daily life. Careful use can reduce fear of lows, smooth out glucose swings, and make clinic visits more productive.

Insert the first sensor with help from your diabetes care team or a trained educator, and set alert ranges that make sense for your current control. Many people start with wider ranges and narrow them over time so alarms stay helpful without becoming constant background noise.

Before each diabetes visit, share CGM reports that show time in range, time below range, and average glucose trends. Those concrete numbers give your clinician a stronger base for adjusting insulin, food patterns, and activity plans in a way that fits your daily life.

Bringing Medicare Coverage And Daily Care Together

A therapeutic continuous glucose monitor can lessen guesswork, lower the risk of dangerous glucose swings, and make living with diabetes feel more manageable. Medicare coverage extends that benefit to many older adults and people with disabilities who might otherwise find CGM systems out of reach.

By learning how Medicare coverage works, confirming that you meet eligibility rules, and working closely with both your clinician and a Medicare enrolled supplier, you can reduce surprises and delays. The device then becomes more than a billed item on a claim form; it becomes a steady flow of data that you and your care team can use to guide safer, smarter decisions day after day.